Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

An online fundraising appeal for coronavirus (COVID-19) research at Oxford has raised more than £50,000 from over 200 individuals after launching just two weeks ago. The donations will be deployed immediately, boosting projects ranging from vaccine development to the delivery of new drugs to treat the virus.

This transmission electron microscope image shows SARS-CoV-2, isolated from a patient in the U.S., emerging from the surface of cells cultured in the lab © NIAID-RML
This transmission electron microscope image shows SARS-CoV-2, isolated from a patient in the U.S., emerging from the surface of cells cultured in the lab

The University is at the forefront of global efforts to understand and control the coronavirus pandemic, with around 90 principal investigators and 1,300 researchers, post-docs and students working around the clock to develop effective vaccines, drugs and public health measures.

Oxford is in a unique position to tackle the pandemic, but access to flexible funding is essential. Donations of all sizes will have an immediate impact on the University’s response to the crisis, filling gaps in funding to ensure that clinical trials can continue, that supply lines keep moving, and that researchers are able to work at both speed and scale.

Read the full story on the University of Oxford Development Office website

Update (16.04.20): The fundraising appeal has now raised a fanastic £85,000 - and counting!

Similar stories

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

COVID-19 is a leading cause of death in children and young people in the US

A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.

Three or more concussions linked with worse brain function in later life

Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.

New blood test could save lives of heart attack victims

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.